hC Bioscience
Sacha Mann is a Senior Partner at Takeda Ventures. She has a decade of experience in venture investing and complementary skills in company creation, management as biotech CEO, business development, and R&D. She has been an advisor and director for various life science companies, incubators/accelerators, and venture capital funds.
Previously she was the CEO of Biosys, a venture-backed clinical-stage microbiome company, and led several healthcare investments at Inventages. Prior to Inventages, Sacha was an early-stage investor focused on innovation and investment at Archangels and BDC Capital. Sacha holds a BSc Honours in Chemistry from the University of British Columbia, an MSc in Biotechnology from Johns Hopkins University, an MBA from Simon Fraser University, and is a Kauffman Fellow.
This person is not in the org chart
This person is not in any offices
hC Bioscience
hC Bioscience, Inc Is an innovator and pioneer of protein editing using gene and context agnostic engineered tRNA Our First in Class approach for protein editing advances beyond genome editing to direct modification of the proteome.